• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vi-SiblinR对憩室病症状及转运时间的影响。

Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease.

作者信息

Ewerth S, Ahlberg J, Holmström B, Persson U, Udén R

出版信息

Acta Chir Scand Suppl. 1980;500:49-50.

PMID:7013392
Abstract

Nine patients complaining of constipation and with diverticuli of the colon on barium-enema were examined with regard to transit-time, bowel movements and subjective symptoms. They were treated with placebo and Vi-SiblinR, using a doubleblind cross-over technique. The transit-time remained normal during the Vi-SiblinR treatment. The feces became softer and increased in weight and the subjective symptoms were significantly reduced (p less than 0,05).

摘要

对9名主诉便秘且钡剂灌肠显示有结肠憩室的患者进行了转运时间、排便情况及主观症状方面的检查。采用双盲交叉技术,让他们分别接受安慰剂和Vi-SiblinR治疗。在Vi-SiblinR治疗期间,转运时间保持正常。粪便变软且重量增加,主观症状显著减轻(p<0.05)。

相似文献

1
Influence on symptoms and transit-time of Vi-SiblinR in diverticular disease.Vi-SiblinR对憩室病症状及转运时间的影响。
Acta Chir Scand Suppl. 1980;500:49-50.
2
[The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo].
Rev Esp Enferm Dig. 1992 Jul;82(1):17-22.
3
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.5天利那洛肽对以便秘为主型肠易激综合征女性患者肠道转运及肠功能的影响
Gastroenterology. 2007 Sep;133(3):761-8. doi: 10.1053/j.gastro.2007.06.067. Epub 2007 Jul 3.
4
A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.一项评估富含膳食纤维的可可壳补充剂对便秘儿科患者结肠转运影响的对照、随机、双盲试验。
Pediatrics. 2006 Sep;118(3):e641-8. doi: 10.1542/peds.2006-0090.
5
Diverticular disease--is it a motility disorder?憩室病——它是一种动力障碍性疾病吗?
Clin Gastroenterol. 1982 Sep;11(3):545-61.
6
Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.秋水仙碱治疗慢性便秘:随机、双盲、安慰剂对照、交叉试验。
Am J Gastroenterol. 2003 May;98(5):1112-6. doi: 10.1111/j.1572-0241.2003.07417.x.
7
Constipation in Parkinson's disease: objective assessment and response to psyllium.帕金森病中的便秘:客观评估及对车前草的反应
Mov Disord. 1997 Nov;12(6):946-51. doi: 10.1002/mds.870120617.
8
Colonic propulsion in diverticular disease, idiopathic constipation, and the irritable colon syndrome.憩室病、特发性便秘和肠易激综合征中的结肠推进运动
Scand J Gastroenterol. 1977;12(3):331-5. doi: 10.3109/00365527709180936.
9
Neurotrophin-3 improves functional constipation.神经营养因子-3可改善功能性便秘。
Am J Gastroenterol. 2003 Jun;98(6):1338-47. doi: 10.1111/j.1572-0241.2003.t01-1-07477.x.
10
The placebo effect. Is it important in diverticular disease?
Am J Gastroenterol. 1977 Feb;67(2):157-62.

引用本文的文献

1
Medical Management of Constipation in Elderly Patients: Systematic Review.老年患者便秘的医学管理:系统评价
J Neurogastroenterol Motil. 2021 Oct 30;27(4):495-512. doi: 10.5056/jnm20210.
2
Influence of Lactitol and Psyllium on Bowel Function in Constipated Indian Volunteers: A Randomized, Controlled Trial.乳果糖和车前子对便秘印度志愿者肠道功能的影响:一项随机对照试验。
Nutrients. 2019 May 21;11(5):1130. doi: 10.3390/nu11051130.
3
Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review.膳食纤维在症状性单纯性憩室病中的作用:一项系统评价
Nutrients. 2017 Feb 20;9(2):161. doi: 10.3390/nu9020161.
4
Treatment of constipation in older people.老年人便秘的治疗。
CMAJ. 2013 May 14;185(8):663-70. doi: 10.1503/cmaj.120819. Epub 2013 Jan 28.
5
A systematic review of high-fibre dietary therapy in diverticular disease.膳食纤维饮食疗法治疗憩室病的系统评价。
Int J Colorectal Dis. 2012 Apr;27(4):419-27. doi: 10.1007/s00384-011-1308-3. Epub 2011 Sep 16.
6
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.美沙拉嗪预防憩室病并发症及症状复发:12个月随访
Dig Dis Sci. 2007 Nov;52(11):2934-41. doi: 10.1007/s10620-007-9766-8. Epub 2007 Apr 5.
7
Efficacy of mesalazine in the treatment of symptomatic diverticular disease.美沙拉嗪治疗有症状憩室病的疗效
Dig Dis Sci. 2005 Mar;50(3):581-6. doi: 10.1007/s10620-005-2478-z.
8
Lack of objective evidence of efficacy of laxatives in chronic constipation.缺乏泻药对慢性便秘疗效的客观证据。
Dig Dis Sci. 2002 Oct;47(10):2222-30. doi: 10.1023/a:1020131126397.
9
What's the 'best buy' for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly.治疗便秘的“最佳选择”是什么?老年人泻药疗效及对比疗效的系统评价结果
Br J Gen Pract. 1999 May;49(442):387-93.